Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats - Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs - Missouri, Idaho, and Kansas Are Suing the FDA Over Ridiculous Fears About Medication Abortions - Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage - Some doctors say the FDA's new notification rule about dense breasts is misleading - FDA will reconsider decision barring copycat versions of Lilly weight loss drug - FDA authorizes over-the-counter combined COVID-19 and flu test